From the food to the vocabulary, there are some huge differences between the US and the UK. Another one is the medication! A ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially inflating costs over the years.

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now ...

Aug 26 (Reuters) - Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99.

is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially inflating costs over the years.

Yes, prescription-free hearing aids are still a thing, and Sony has refined some hearing features for the new CRE-C20. Jessica is a writer on the Wellness team with a focus on health technology ...

The case accuses UnitedHealth Group’s Optum unit, CVS Health’s CVS Caremark and ... their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their ...

Other days, I wonder if I should call my doctor. The Stelo is unique in that it’s one of three FDA-cleared over-the-counter CGMs. (The other two are from Abbott.) Typically, CGMs have been used ...

hypersensitivity or any other contraindication to omeprazole; blood donation within 3 months prior to screening; medication with any 'over-the-counter' (OTC) or prescribed drug within 1 week prior ...

(NYSE:CVS) stands against the other Fortune 500 stocks. The aggregate revenue of the Fortune 500 companies in 2023 reached a record $41 trillion, up 0.1% year-over-year. Profits also rose 2% after ...